叶酸受体针对癌症的嵌合体的开发 选择性降解细胞外蛋白的细胞外蛋白
Yaxian Zhou1, Chunrong Li1, Xuankun Chen1
1Lachman Institute of Pharmaceutical Development, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Nature communications
|October 8, 2024
概括
研究人员开发了叶酸受体向金马 (FRTACs) 来降解细胞外癌症蛋白质. 这种新的方法针对恶性细胞,为癌症治疗和研究提供了一个更精确和更容易访问的平台.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 有针对性的蛋白质降解利用细胞机械来去除特定的蛋白质.
- 细胞内蛋白质的降解显示出临床益处,最近在细胞外蛋白质的溶酶体降解方面取得了进展.
- 疾病相关细胞的选择性降解仍然是精准医学的一个挑战.
研究的目的:
- 开发一个可访问的平台,用于癌细胞中细胞外蛋白的有针对性的降解.
- 通过选择性地准与癌症相关的蛋白质来增强精确医学.
- 创建用于癌症研究和治疗的多功能化学探针和治疗方法.
主要方法:
- 设计的叶酸受体向金马 (FRTACs) 来招募叶酸受体.
- 利用FRTAC来准癌细胞中的细胞外可溶性和膜蛋白.
- 在体外和体内评估FRTAC疗效.
主要成果:
- FRTACs成功地招募了叶酸受体,主要表达在恶性细胞上.
- 已证明细胞外可溶性和膜癌相关蛋白质的降解.
- FRTACs在体外和体内都被证明是有效的.
结论:
- FRTACs代表了一个易于获得的分子类别,用于向蛋白质降解.
- 这个平台能够精确地准癌细胞中的细胞外蛋白.
- FRTAC为开发新型癌症疗法和化学探针提供了可通用的方法.
更多相关视频
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
9.5K
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.5K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
